#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17322	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2131	808.9	0	.	n	.	0	C451T	SNP	451	451	C	685	685	T	1003	T,C	908,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17322	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2131	808.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	1093	C,T	979,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31906	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3469	916.4	0	.	n	.	0	T695C	SNP	695	695	T	995	995	C	946	C,T	830,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31906	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3469	916.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2271	2271	C	1009	C	900	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31906	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3469	916.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2345	2345	A	936	A	844	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31906	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3469	916.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2897	2897	C	986	C,T,A,G	894,1,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31906	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3469	916.4	0	HET	.	.	.	A1638G	.	1638	1638	A	1938	1938	A	1065	A,G	741,205	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31906	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3469	916.4	0	HET	.	.	.	G2616A,T	.	2616	2616	G	2916	2916	G	998	G,A,T	718,182,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2480	folP	855	855	100.0	folP.l15.c30.ctg.1	1620	152.5	1	SNP	p	R229S	1	.	.	685	687	AGC	988	990	AGC	277;274;275	A;G;C	257;253;254	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6182	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3485	177.1	1	SNP	p	S91F	1	.	.	271	273	TTC	699	701	TTC	222;223;225	T;T;C	200;201;201	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6182	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3485	177.1	1	SNP	p	D95G	1	.	.	283	285	GGC	711	713	GGC	223;224;223	G;G;C	200;204;203	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6182	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3485	177.1	1	SNP	p	G95N	0	.	.	283	285	GGC	711	713	GGC	223;224;223	G;G;C	200;204;203	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1992	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1038	188.6	1	SNP	p	G45D	0	.	.	133	135	GGC	342	344	GGC	271;270;272	G;G;C	245;243;243	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	946	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	989	95.2	0	.	n	.	0	A197.	DEL	197	197	A	505	505	A	233	A	211	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6038	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2924	206.0	1	SNP	p	D86N	0	.	.	256	258	GAC	524	526	GAC	296;296;292	G;A;C	262;259;263	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6038	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2924	206.0	1	SNP	p	S87R	1	.	.	259	261	CGT	527	529	CGT	291;288;288	C;G;T	263;259;252	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6038	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2924	206.0	1	SNP	p	R87W	0	.	.	259	261	CGT	527	529	CGT	291;288;288	C;G;T	263;259;252	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6038	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2924	206.0	1	SNP	p	R87I	0	.	.	259	261	CGT	527	529	CGT	291;288;288	C;G;T	263;259;252	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6038	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2924	206.0	1	SNP	p	S88P	0	.	.	262	264	TCC	530	532	TCC	285;285;289	T,C;C;C	252,1;258;258	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5264	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2573	203.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1508	1510	GGC	235;236;241	G;G;C	211;212;214	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2315	206.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1173	1175	GCC	285;288;289	G,A;C;C	259,1;265;263	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2315	206.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1176	1178	ATG	293;292;288	A;T;G,A	266;268;263,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2315	206.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1188	1190	ACC	286;285;287	A;C;C	264;264;266	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2315	206.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1188	1190	ACC	286;285;287	A;C;C	264;264;266	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2315	206.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1689	1691	ACC	259;259;258	A;C;C	224;229;230	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2315	206.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1743	1745	GCG	257;256;258	G;C;G	234;231;237	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2315	206.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1743	1745	GCG	257;256;258	G;C;G	234;231;237	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2315	206.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1866	1868	GGT	229;228;227	G;G;T	201;200;195	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2315	206.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1875	1877	AGC	223;226;226	A;G;C	192;191;191	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4800	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2315	206.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1893	1895	CCG	193;195;192	C,G;C,G;G	143,6;144,1;139	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6610	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3031	217.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1632	1634	CCG	260;261;263	C,G;C;G	222,1;230;224	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2402	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1852	129.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	676	676	C	160	C	140	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3514	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1540	226.9	0	.	p	.	0	G210R	NONSYN	628	630	GGA	893	895	AGA	292;296;301	A;G,A;A	264;267,1;271	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3514	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1540	226.9	0	.	p	.	0	S217G	NONSYN	649	651	AGT	914	916	GGT	300;300;298	G;G;T	269;271;269	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3514	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1540	226.9	1	SNP	p	G120K	1	.	.	358	360	AAG	623	625	AAG	297;293;297	A,C;A;G	269,1;269;262	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3514	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1540	226.9	1	SNP	p	A121N	1	.	.	361	363	AAC	626	628	AAC	295;293;289	A;A;C	264;267;263	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3514	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1540	226.9	1	SNP	p	N121D	0	.	.	361	363	AAC	626	628	AAC	295;293;289	A;A;C	264;267;263	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12672	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4720	267.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1228	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	916	132.4	1	SNP	p	V57M	1	.	.	169	171	ATG	432	434	ATG	273;274;276	A;T;G	244;246;246	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
